Press Releases about Veracyte Inc![]()
Veracyte Names Phillip G. Febbo, M.D., as Chief Scientific Officer and Chief Medical Officer
September 27, 2023
From Veracyte, Inc.
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() From Veracyte, Inc.
Via Business Wire
![]()
Veracyte Announces Second Quarter 2023 Financial Results
August 08, 2023
From Veracyte, Inc.
Via Business Wire
![]() ![]() ![]() ![]() From Veracyte, Inc.
Via Business Wire
![]() ![]() ![]() From Veracyte, Inc.
Via Business Wire
![]() ![]() Via PressReach
Exposures
Product Safety
![]() From Veracyte, Inc.
Via Business Wire
![]() ![]() ![]() Via PressReach
![]()
Veracyte Announces Release of Inaugural ESG Report
May 03, 2023
From Veracyte, Inc.
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() From Veracyte, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|